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Background
Patients with rheumatoid arthritis (RA) experience an
excess risk of congestive heart failure (CHF), chronic
inflammation plays a pivotal role in this increased risk.
Despite the growing body of research on cardiovascular
(CV) disease in RA, the key pathways underlying the
development of abnormalities in myocardial structure
and function associated with CHF remain obscure. Car-
diac magnetic resonance imaging (CMR) has been used
to identify early functional and structural changes in the
left ventricle (LV) before development of clinically overt
CHF. We evaluated LV function and structure using a
CMR in RA patients (pts) without cardiac symptoms,
and determined the impact of non-biologic DMARDs
and biologic DMARDs.
Methods
Consecutive RA pts and healthy control were enrolled. RA
pts received biologic DMARDs (bDMARDs) or non-biolo-
gic DMARDs (nbDMARDs). All subjects underwent eva-
luation of LV function and structure using non-contrast
CMR. LV function was based on LV ejection fraction (EF),
end-systolic volume (ESV), end-diastolic volume (EDV),
stroke volume (SV), and cardiac output (CO). LV hyper-
trophy was measured by absolute LV mass (LVM) and LV
mass index (LVMI) determined by LVM/body surface
area. Subjects were classified into four categories based on
LVMI and LVM/EDV of control subjects, with the mean
+ 2 SD of each measure defined as elevated LVMI and
LVM/EDV.
Results
We compared 90 female RA pts (mean age, 55.9±7.1
years) with a matched 20-patient control group (mean age,
52.7±4.6 years). 46 RA pts received nbDMARDs [43,
methotrexate (MTX); 3, other drugs)] and 44 RA pts
received bDMARDs [(18, infliximab; 26, tocilizumab) plus
MTX]. The Simplified Disease Activity Index (SDAI) was
significantly higher in the nbDMARDs group than in the
bDMARDs group (p=0.002). Compared to the control
group, the nbDMARDs group showed significantly higher
LVMI and lower EF (p<0.001, p=0.003, respectively).
There were no significant differences in LVMI and
EF between the control and the bDMARDs groups. LV
structure was classified as (1) concentric remodeling
(LVMI<66.9 and LVM/EDV>1.02 (2) concentric hypertro-
phy (LVMI>66.9 and LVM/EDV>1.02 (3) eccentric hyper-
trophy (LVMI>66.9 and LVM/EDV <1.02 and (4) normal
geometry (LVMI<66.9 and LVM/EDV<1.02. Among those
with abnormal LV geometry, 32% of RA patients in the
nbDMARDs group showed eccentric hypertrophy. 98% of
RA patients in the bDMARDs group showed normal geo-
metry. LVMI and EF were significantly associated with
SDAI (r=0.567, p<0.001; r=0.412, p=0.02, respectively).
Mass/EDV tended to be associated with SDAI (p=0.07).
Adjustment for ESR did not modify the association of
SDAI with EF and LVMI (p=0.017, p=0.005, respectively).
Conclusions
Biologics treatment may reduce progression of subclinical
LV dysfunction and normalize LV structure in association
with the reduction in disease activity. It can be presumed
that active RA may be an important contributor to the
development of myocardial abnormalities.
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